NF-κB perturbation reveals unique immunomodulatory functions in Prx1 <sup>+</sup> fibroblasts that promote development of atopic dermatitis

Kang I. Ko(University of Pennsylvania), Jean Merlet(University of Tennessee at Knoxville), Brett P. DerGarabedian(University of Pennsylvania), Zhen Huang(King University), Y Horiuchi(University of Pennsylvania), Matthew L. Hedberg(University of Pennsylvania), Eileen Hu(University of Pennsylvania), Anh Nguyen(University of Pennsylvania), Stephen M. Prouty(University of Pennsylvania), Faizan Alawi(University of Pennsylvania), Matthew C. Walsh(University of Pennsylvania), Yongwon Choi(University of Pennsylvania), Sarah E. Millar(Icahn School of Medicine at Mount Sinai), Ashley Cliff(University of Tennessee at Knoxville), Jonathon Romero(University of Tennessee at Knoxville), Michael R. Garvin(Oak Ridge National Laboratory), John T. Seykora(University of Pennsylvania), Daniel Jacobson(Oak Ridge National Laboratory), Dana T. Graves(University of Pennsylvania)
Science Translational Medicine
February 2, 2022
Cited by 72Open Access
Full Text

Abstract

Skin is composed of diverse cell populations that cooperatively maintain homeostasis. Up-regulation of the nuclear factor κB (NF-κB) pathway may lead to the development of chronic inflammatory disorders of the skin, but its role during the early events remains unclear. Through analysis of single-cell RNA sequencing data via iterative random forest leave one out prediction, an explainable artificial intelligence method, we identified an immunoregulatory role for a unique paired related homeobox-1 (Prx1) + fibroblast subpopulation. Disruption of Ikkb –NF-κB under homeostatic conditions in these fibroblasts paradoxically induced skin inflammation due to the overexpression of C-C motif chemokine ligand 11 (CCL11; or eotaxin-1) characterized by eosinophil infiltration and a subsequent T H 2 immune response. Because the inflammatory phenotype resembled that seen in human atopic dermatitis (AD), we examined human AD skin samples and found that human AD fibroblasts also overexpressed CCL11 and that perturbation of Ikkb –NF-κB in primary human dermal fibroblasts up-regulated CCL11. Monoclonal antibody treatment against CCL11 was effective in reducing the eosinophilia and T H 2 inflammation in a mouse model. Together, the murine model and human AD specimens point to dysregulated Prx1 + fibroblasts as a previously unrecognized etiologic factor that may contribute to the pathogenesis of AD and suggest that targeting CCL11 may be a way to treat AD-like skin lesions.


Related Papers

No related papers found

Powered by citation graph analysis